Disparities in Listing With a Durable Left Ventricular Assist Device After 2018 Heart Allocation Policy Change

Alexander Z Wang1, Molly H White2, Nikhil Narang3

  • 1Department of Medicine, University of Southern California, Los Angeles, California, USA.

JACC. Heart Failure
|August 5, 2026
PubMed

Insights

After the 2018 heart policy change, vulnerable patients were more likely to receive a durable left ventricular assist device (LVAD) bridge-to-transplant. This may worsen transplant disparities, requiring policy changes for equitable heart allocation.

Area of Science:

  • Cardiology
  • Transplant Surgery
  • Health Equity

Background:

  • The 2018 U.S. heart allocation policy shift reduced the use of bridge-to-transplant (BTT) durable left ventricular assist device (LVAD) strategies.
  • Previous research indicates patients with BTT LVADs face lower transplant rates under the current policy.
  • Candidates from vulnerable communities experience reduced transplant rates post-listing.

Purpose of the Study:

  • To investigate if the 2018 policy change disproportionately affected the listing of vulnerable patients with BTT LVADs.
  • To analyze the impact of neighborhood deprivation on BTT LVAD listing post-policy change.

Main Methods:

  • Utilized data from the Scientific Registry of Transplant Recipients (SRTR) for adult heart transplant candidates listed between 2014-2024.
  • Divided candidates into prepolicy and postpolicy cohorts based on the October 18, 2018 policy change.
  • Employed mixed-effects logistic regression to assess the association between Area Deprivation Index (ADI) and BTT LVAD listing, adjusting for candidate and center characteristics.

Main Results:

  • The study included 43,342 candidates; BTT LVAD use decreased from 25% prepolicy to 18% postpolicy.
  • The interaction between ADI and policy period significantly impacted BTT LVAD listing odds (P < 0.001).
  • Postpolicy, candidates in the most deprived areas (10th ADI decile) had 59% higher odds of BTT LVAD listing compared to the least deprived (1st decile).

Conclusions:

  • The 2018 policy change led to increased BTT LVAD listing likelihood in vulnerable populations.
  • This practice may exacerbate existing disparities in heart transplant access.
  • Policy adjustments are necessary to promote equity in BTT LVAD listing and heart allocation.
Abstract

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...